Health Regulation Circulars
Health Circulars & Consultations for all Health Facilities and Health Professionals Licensed by Dubai Health Authority.
Reference: CIR-2026-00000029
Circular No. ( 12 /2026) Recall of Specific Batches of Isotonac-4Reference: CIR-2026-00000028
Circular No. ( 11 /2026) Recall of Specific Lots of the Medical Product Rosabella Moringa capsuleReference: CIR-2026-00000027
External Circular: Updated Clinical Guidelines for Best Practice in Immunization – Version (4)Reference: CIR-2026-00000020
External Circular-Guidelines for Reporting Healthcare Accreditors Indicators– Version 1Reference: CIR-2026-00000019
External Circular-Standards for Platelet-Rich Plasma– Version 1Reference: CIR-2026-00000018
External Circular-Standards for Hyperbaric Oxygen Therapy ( HBOT) Services – Version 2.2Reference: CIR-2026-00000016
Circular No. (4/2026) : Precautionary Recall of Nutricia (Danone) Infant and Follow-On Formula ProductsReference: CIR-2026-00000013
External Circular: Enhancing Surveillance of Middle East Respiratory Syndrome Virus (MERS-CoV)Reference: CIR-2026-00000012
Circular No. ( 3/2026 ) Update on the Precautionary Recall of Nestlé Infant and Follow-On Formula ProductsReference: CIR-2026-00000010
External Circular - Standards for Assisted Reproductive Medicine CenterReference: CIR-2026-00000006
External Circular: Implementation of the National School Health Screening Guidelines – Academic Year 2026–2027Reference: CIR-2026-00000008
"Facility Mandatory Records" Awareness Workshop For Healthcare FacilitiesReference: CIR-2026-00000007
External Circular: Surveillance of Dengue Fever Cases in DubaiReference: CIR-2026-00000002
External Circular: Approval of Health Campaigns and Programs in SchoolsReference: CIR-2026-00000003
Update: Precautionary Recall of Nestlé Infant and Follow-On Formula ProductsReference: CIR-2026-00000001
Precautionary Recall of Nestlé Infant and Follow-On Formula ProductsReference: CIR-2025-00000238
External Circular: Automatic Electronic Audit of Health Facilities through The "RASAD 2" SystemReference: CIR-2025-00000237
Awareness Circular – Waring about using the falsified lots of IBRANCE (palbociclib) product.Do you find this Content helpful?